143 related articles for article (PubMed ID: 26056301)
21. E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells.
Garneau H; Paquin MC; Carrier JC; Rivard N
J Cell Physiol; 2009 Nov; 221(2):350-8. PubMed ID: 19562678
[TBL] [Abstract][Full Text] [Related]
22. Transcription factor ZBED6 affects gene expression, proliferation, and cell death in pancreatic beta cells.
Wang X; Jiang L; Wallerman O; Engström U; Ameur A; Gupta RK; Qi Y; Andersson L; Welsh N
Proc Natl Acad Sci U S A; 2013 Oct; 110(40):15997-6002. PubMed ID: 24043816
[TBL] [Abstract][Full Text] [Related]
23. Transcriptome profile of human colorectal adenomas.
Sabates-Bellver J; Van der Flier LG; de Palo M; Cattaneo E; Maake C; Rehrauer H; Laczko E; Kurowski MA; Bujnicki JM; Menigatti M; Luz J; Ranalli TV; Gomes V; Pastorelli A; Faggiani R; Anti M; Jiricny J; Clevers H; Marra G
Mol Cancer Res; 2007 Dec; 5(12):1263-75. PubMed ID: 18171984
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression.
Pagliuca A; Valvo C; Fabrizi E; di Martino S; Biffoni M; Runci D; Forte S; De Maria R; Ricci-Vitiani L
Oncogene; 2013 Oct; 32(40):4806-13. PubMed ID: 23128394
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T
Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951
[TBL] [Abstract][Full Text] [Related]
26. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin.
Dong YB; Yang HL; McMasters KM
Cancer Gene Ther; 2003 Mar; 10(3):168-78. PubMed ID: 12637937
[TBL] [Abstract][Full Text] [Related]
27. Identification of AF17 as a downstream gene of the beta-catenin/T-cell factor pathway and its involvement in colorectal carcinogenesis.
Lin YM; Ono K; Satoh S; Ishiguro H; Fujita M; Miwa N; Tanaka T; Tsunoda T; Yang KC; Nakamura Y; Furukawa Y
Cancer Res; 2001 Sep; 61(17):6345-9. PubMed ID: 11522623
[TBL] [Abstract][Full Text] [Related]
28. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
[TBL] [Abstract][Full Text] [Related]
29. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia.
Kaidi A; Qualtrough D; Williams AC; Paraskeva C
Cancer Res; 2006 Jul; 66(13):6683-91. PubMed ID: 16818642
[TBL] [Abstract][Full Text] [Related]
30. GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells.
Shureiqi I; Jiang W; Fischer SM; Xu X; Chen D; Lee JJ; Lotan R; Lippman SM
Cancer Res; 2002 Feb; 62(4):1178-83. PubMed ID: 11861401
[TBL] [Abstract][Full Text] [Related]
31. Effect of Zbed6 Single-Allele Knockout on the Growth and Development of Skeletal Muscle in Mice.
Liu L; Wang S; Tian W; Xu C; Wei C; Cui K; Jiang L; Wang D
Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829600
[TBL] [Abstract][Full Text] [Related]
32. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
[TBL] [Abstract][Full Text] [Related]
33. Efficient Editing of the ZBED6-Binding Site in Intron 3 of IGF2 in a Bovine Model Using the CRISPR/Cas9 System.
Zou H; Yu D; Yao S; Ding F; Li J; Li L; Li X; Zhao S; Pang Y; Hao H; Du W; Zhao X; Dai Y; Zhu H
Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885915
[TBL] [Abstract][Full Text] [Related]
34. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
35. The role of p16 in the E2F-dependent thymidine kinase regulation.
Hengstschläger M; Hengstschläger-Ottnad E; Pusch O; Wawra E
Oncogene; 1996 Apr; 12(8):1635-43. PubMed ID: 8622883
[TBL] [Abstract][Full Text] [Related]
36. FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma.
Zhu XL; Zeng YF; Guan J; Li YF; Deng YJ; Bian XW; Ding YQ; Liang L
J Pathol; 2011 Jul; 224(3):377-88. PubMed ID: 21506128
[TBL] [Abstract][Full Text] [Related]
37. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.
Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T
Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838
[TBL] [Abstract][Full Text] [Related]
38. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
[TBL] [Abstract][Full Text] [Related]
39. Functional impact of colorectal cancer-associated mutations in the transcription factor E2F4.
Paquin MC; Leblanc C; Lemieux E; Bian B; Rivard N
Int J Oncol; 2013 Dec; 43(6):2015-22. PubMed ID: 24100580
[TBL] [Abstract][Full Text] [Related]
40. LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein.
Abdollahi A; Bao R; Hamilton TC
Oncogene; 1999 Nov; 18(47):6477-87. PubMed ID: 10597250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
